What is the current price and short-term trend for NOVN.SW stock?

NOVN.SW stock trades at **CHF113.84** pre-market on 13 Jan 2026. The short-term trend shows overbought signals: **RSI 74.23** and Stochastic %K **92.86**, suggesting possible consolidation or a pullback in the coming sessions.

How does Novartis’s valuation compare to peers?

Novartis trades at **PE 19.53**, below some large healthcare peers by PE but above sector averages on price-to-book **6.34**. Strong ROE **34.12%** and free cash flow yield **6.68%** help justify the premium multiples.

What are Meyka AI’s key forecasts for NOVN.SW stock?

Meyka AI's forecast model projects one-year **CHF100.53** (implied -11.67%) and five-year **CHF123.85** (implied +8.80%) versus the current **CHF113.84**. These are model-based projections and not guarantees.

When is the next major catalyst for NOVN.SW stock?

Novartis will report earnings on **4 Feb 2026**. That report is the primary near-term catalyst and could move the stock materially depending on Innovative Medicines results and Sandoz guidance.

CH Stocks

CHF113.84 Novartis AG (NOVN.SW, SIX) pre-market 13 Jan 2026: most active, earnings watch

ByHuzaifa Zahoor January 13, 2026

We see NOVN.SW stock trading at CHF113.84 in the SIX pre-market session on 13 Jan 2026, down 0.18% from the previous close. Volume sits at 2,045,536 shares against a 3-month average near 2,909,423, making Novartis one of today’s most active names on the Switzerland market. Investors are watching upcoming earnings and valuation signals as the stock trades above its 50-day average CHF106.46 and 200-day average CHF99.17.